Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CollPlant Biotechnologies (CLGN) Return on Capital Employed (2018 - 2025)

CollPlant Biotechnologies filings provide 8 years of Return on Capital Employed readings, the most recent being 18.75% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 2217.0% to 18.75% in Q4 2025 year-over-year; TTM through Dec 2025 was 18.75%, a 2217.0% decrease, with the full-year FY2025 number at 95.09%, down 2152.0% from a year prior.
  • Return on Capital Employed hit 18.75% in Q4 2025 for CollPlant Biotechnologies, up from 20.22% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 121.52% in Q1 2021 to a low of 61.65% in Q2 2025.
  • Median Return on Capital Employed over the past 5 years was 8.93% (2024), compared with a mean of 6.81%.
  • Biggest five-year swings in Return on Capital Employed: soared 16812bps in 2021 and later plummeted -13459bps in 2022.
  • CollPlant Biotechnologies' Return on Capital Employed stood at 0.13% in 2021, then plummeted by -20257bps to 26.52% in 2022, then soared by 87bps to 3.43% in 2023, then skyrocketed by 200bps to 3.42% in 2024, then tumbled by -648bps to 18.75% in 2025.
  • The last three reported values for Return on Capital Employed were 18.75% (Q4 2025), 20.22% (Q3 2025), and 61.65% (Q2 2025) per Business Quant data.